Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Welkos, Susan L ^a   Klimko, Christopher P ^a   Kern, Steven J ^a   Bearss, Jeremy J ^a   Bozue, Joel A ^a   Bernhards, Robert C ^a   Trevino, Sylvia R ^a   Waag, David M ^a   Amemiya, Kei ^a   Worsham, Patricia L ^a   Cote, Christopher K ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; CYTOTOXICITY; HOST CELL; IN VITRO STUDY; INFECTION SENSITIVITY; LIVER ABSCESS; MACROPHAGE; MELIOIDOSIS; MOUSE; NONHUMAN; PHAGOCYTOSIS; SKIN ABSCESS; SPLEEN ABSCESS; STRAIN DIFFERENCE; ABSCESS; ANIMAL; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHENOTYPE;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA PSEUDOMALLEI; MURINAE; MUS; NEGIBACTERIA;

LIPOPOLYSACCHARIDE;

ABSCESS; ANIMALS; BURKHOLDERIA PSEUDOMALLEI; DISEASE MODELS, ANIMAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MELIOIDOSIS; MICE; PHENOTYPE;

EID: 84929483923     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124667     Document Type: Article

References (98)

1. Allwood EM, Devenish RJ, Prescott M, Adler B, Boyce JD (2011) Strategies for Intracellular Survival of Burkholderia pseudomallei. Front Microbiol 2: 170. doi: 10.3389/fmicb.2011.00170 PMID: 22007185
2. Vietri NJ, DeShazer D (2007) Melioidosis. In: Dembek Z, editor. Textbook of Military Medicine: Medical Aspect of Biological Warfare. Washington, D.C.: Borden Institute Walter Reed Army Medical Center. pp. 147-166.
3. Wiersinga WJ, Currie BJ, Peacock SJ (2012) Melioidosis. N Engl J Med 367: 1035-1044. doi: 10.1056/NEJMra1204699 PMID: 22970946
4. Cheng AC, Currie BJ (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383-416. PMID: 15831829
5. Dance DA (1991) Melioidosis: the tip of the iceberg? Clin Microbiol Rev 4: 52-60. PMID: 2004347
6. Dance DA (2000) Melioidosis as an emerging global problem. Acta Trop 74: 115-119. PMID: 10674638
7. Lo TJ, Ang LW, James L, Goh KT (2009) Melioidosis in a tropical city state, Singapore. Emerg Infect Dis 15: 1645-1647. doi: 10.3201/eid1510.090246 PMID: 19861063
8. Rammaert B, Beaute J, Borand L, Hem S, Buchy P, Goyet S, et al. (2011) Pulmonary melioidosis in Cambodia: a prospective study. BMC Infect Dis 11: 126. doi: 10.1186/1471-2334-11-126 PMID: 21569563
9. Yabuuchi E, Arakawa M (1993) Burkholderia pseudomallei and melioidosis: be aware in temperate area. Microbiol Immunol 37: 823-836. PMID: 7507550
10. O'Sullivan BP, Torres B, Conidi G, Smole S, Gauthier C, Stauffer KE, et al. (2011) Burkholderia pseudomallei infection in a child with cystic fibrosis: acquisition in the Western Hemisphere. Chest 140: 239-242. doi: 10.1378/chest.10-3336 PMID: 21729895
11. Aardema H, Luijnenburg EM, Salm EF, Bijlmer HA, Visser CE, Van't Wout JW. (2005) Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil. Epidemiol Infect 133: 871-875. PMID: 16181507
12. Doker TJ, Sharp TM, Rivera-Garcia B, Perez-Padilla J, Benoit TJ, Ellis EM, et al. (2014) Contact Investigation of Melioidosis Cases Reveals Regional Endemicity in Puerto Rico. Clin Infect Dis 60(2): 243-250. doi: 10.1093/cid/ciu764 PMID: 25270646
13. Gee JE, Allender CJ, Tuanyok A, Elrod MG, Hoffmaster AR (2014) Burkholderia pseudomallei type G in Western Hemisphere. Emerg Infect Dis 20: 682-684. doi: 10.3201/eid2004.130960 PMID: 24655932
14. Sprague LD, Neubauer H (2004) Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public Health 51: 305-320. PMID: 15525357
15. Zehnder AM, Hawkins MG, Koski MA, Lifland B, Byrne BA, Swanson AA, et al. (2014) Burkholderia pseudomallei isolates in 2 pet iguanas, California, USA. Emerg Infect Dis 20: 304-306. doi: 10.3201/eid2002.131314 PMID: 24447394
16. Currie BJ, Jacups SP (2003) Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis 9: 1538-1542. PMID: 14720392
17. Hassan MR, Pani SP, Peng NP, Voralu K, Vijayalakshmi N, Mehanderkar R, et al. (2010) Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis 10: 302. doi: 10.1186/1471-2334-10-302 PMID: 20964837
18. Liu X, Pang L, Sim SH, Goh KT, Ravikumar S, Win MS, et al. (2015) Association of melioidosis incidence with rainfall and humidity, singapore, 2003-2012. Emerg Infect Dis 21: 159-162. doi: 10.3201/eid2101.140042 PMID: 25531547
19. Currie BJ, Fisher DA, Anstey NM, Jacups SP (2000) Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 94: 301-304. PMID: 10975006
20. Suputtamongkol Y, ChaowagulW, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, Ruchutrakool T, et al. (1999) Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 29: 408-413. PMID: 10476750
21. Gan YH (2005) Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? J Infect Dis 192: 1845-1850. PMID: 16235187
22. Kronmann KC, Truett AA, Hale BR, Crum-Cianflone NF (2009) Melioidosis after brief exposure: a serologic survey in US Marines. Am J Trop Med Hyg 80: 182-184. PMID: 19190209
23. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G (2005) Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 43: 970-972. PMID: 15695721
24. Zhang B, Wear DJ, Kim HS, Weina P, Stojadinovic A, Izadjoo M. (2012) Development of hydrolysis probe-based real-time PCR for identification of virulent gene targets of Burkholderia pseudomallei and B. mallei - a retrospective study on archival cases of service members with melioidosis and glanders. Mil Med 177: 216-221. PMID: 22360070
25. Dance D (2014) Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents 43: 310-318. doi: 10.1016/j.ijantimicag.2014.01.005 PMID: 24613038
26. Van Zandt KE, Tuanyok A, Keim PS, Warren RL, Gelhaus HC (2012) An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing. Front Cell Infect Microbiol 2: 120. doi: 10.3389/fcimb.2012.00120 PMID: 23057010
27. Yi EC, Hackett M (2000) Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria. Analyst 125: 651-656. PMID: 10892021
28. Tsai CM, Frasch CE (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119. PMID: 6176137
29. Arjcharoen S, Wikraiphat C, Pudla M, Limposuwan K, Woods DE, Sirisinha S, et al. (2007) Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival. Infect Immun 75: 4298-4304. PMID: 17576760
30. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, et al. (2011) The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun 79: 1512-1525. doi: 10.1128/IAI.01218-10 PMID: 21300775
31. Kespichayawattana W, Rattanachetkul S, Wanun T, Utaisincharoen P, Sirisinha S (2000) Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun 68: 5377-5384. PMID: 10948167
32. Tandhavanant S, Thanwisai A, Limmathurotsakul D, Korbsrisate S, Day NP, Peacock SJ, et al. (2010) Effect of colony morphology variation of Burkholderia pseudomallei on intracellular survival and resistance to antimicrobial environments in human macrophages in vitro. BMC Microbiol 10: 303. doi: 10.1186/1471-2180-10-303 PMID: 21114871
33. Davis KJ, Vogel P, Fritz DL, Steele KE, Pitt ML, Welkos SL, et al. (1997) Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice. Arch Pathol Lab Med 121: 865-868. PMID: 9278616
34. Gelman A, Jakulin A, Pittau MG, Su YS (2008) A weakly informative default prior distribution for logistic and other regression models. The Annals of Applied Statisitics: 1360-1383.
35. Hoffman MD, Gelman A (2011) The No-U-Turn Sampler: Adaptively Setting Path Lenghts in Hamiltonian Monte Carlo. Version 1 ed.
36. Team SD (2013) Atna: A C++Library for probability and sampling. 2.1 ed.
37. Team SD (2014) RStan: the R interface to Stan. 2.2 ed.
38. Anuntagool N, Wuthiekanun V, White NJ, Currie BJ, Sermswan RW, Wongratanacheewin S, et al. (2006) Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg 74: 348-352. PMID: 16525090
39. Tuanyok A, Stone JK, Mayo M, Kaestli M, Gruendike J, Georgia S, et al. (2012) The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Negl Trop Dis 6: e1453. doi: 10.1371/journal.pntd.0001453 PMID: 22235357
40. Dannenberg AM Jr., Scott EM (1958) Melioidosis: pathogenesis and immunity in mice and hamsters. I. Studies with virulent strains of Malleomyces pseudomallei. J Exp Med 107: 153-166. PMID: 13481262
41. Fritz DL, Vogel P, Brown DR, Deshazer D, Waag DM (2000) Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet Pathol 37: 626-636. PMID: 11105952
42. Hoppe I, Brenneke B, Rohde M, Kreft A, Haussler S, Reganzerowski A,et al. (1999) Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun 67: 2891-2900. PMID: 10338496
43. Tarlow MJ, Lloyd J (1971)Melioidosis and chronic granulomatous disease. Proc R Soc Med 64: 19-20. PMID: 4101498
44. Wong KT, Puthucheary SD, Vadivelu J (1995) The histopathology of human melioidosis. Histopathology 26: 51-55. PMID: 7713483
45. Santanirand P, Harley VS, Dance DA, Drasar BS, Bancroft GJ (1999) Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun 67: 3593-3600. PMID: 10377144
46. Meumann EM, Cheng AC, Ward L, Currie BJ (2012) Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 54: 362-369. doi: 10.1093/cid/cir808 PMID: 22057702
47. Saonanon P, Tirakunwichcha S, ChierakulW(2013) Case report of orbital cellulitis and necrotizing fasciitis from melioidosis. Ophthal Plast Reconstr Surg 29: e81-84. doi: 10.1097/IOP.0b013e318275b601 PMID: 23303132
48. Parkes JD, Kline KL, Riedesel EA, Haynes JS (2009) A vascular hamartoma arising from the cervical spine of a cat. J Feline Med Surg 11: 724-727. doi: 10.1016/j.jfms.2008.09.009 PMID: 19564125
49. Currie BJ (2003) Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions. Eur Respir J 22: 542-550. PMID: 14516149
50. Evans E, Poxton IR, Govan JR (1999) Lipopolysaccharide chemotypes of Burkholderia cepacia. J Med Microbiol 48: 825-832. PMID: 10482293
51. Shaw D, Poxton IR, Govan JR (1995) Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol 11: 99-106. PMID: 7640678
52. Nandi T, Tan P (2013) Less is more: Burkholderia pseudomallei and chronic melioidosis. MBio 4: e00709-00713. doi: 10.1128/mBio.00709-13 PMID: 24065633
53. Price EP, Hornstra HM, Limmathurotsakul D, Max TL, Sarovich DS, Vogler AJ, et al. (2010) Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis. PLoS Pathog 6: e1000725. doi: 10.1371/journal.ppat.1000725 PMID: 20090837
54. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487-8492. PMID: 16687478
55. Massey S, Yeager LA, Blumentritt CA, Vijayakumar S, Sbrana E, Peterson JW, et al. (2014) Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection. Sci Rep 4: 4305. doi: 10.1038/srep04305 PMID: 24603493
56. Titball RW, Russell P, Cuccui J, Easton A, Haque A, Atkins T, et al. (2008) Burkholderia pseudomallei: animal models of infection. Trans R Soc Trop Med Hyg 102 Suppl 1: S111-116. doi: 10.1016/S0035-9203(08)70026-9 PMID: 19121670
57. Nieves W, Petersen H, Judy BM, Blumentritt CA, Russell-Lodrigue K, Roy CJ, et al. (2014) A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin Vaccine Immunol 21: 747-754. doi: 10.1128/CVI.00119-14 PMID: 24671550
58. Chua KL, Chan YY, Gan YH (2003) Flagella are virulence determinants of Burkholderia pseudomallei. Infect Immun 71: 1622-1629. PMID: 12654773
59. Tan GY, Liu Y, Sivalingam SP, Sim SH, Wang D, Paucod JC, et al. (2008) Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med Microbiol 57: 508-515. doi: 10.1099/jmm.0.47596-0 PMID: 18349373
60. Barnes JL, Ketheesan N (2005) Route of infection in melioidosis. Emerg Infect Dis 11: 638-639. PMID: 15834987
61. Harland DN, Chu K, Haque A, Nelson M, Walker NJ, Sarkar-Tyson M, et al. (2007) Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Infect Immun 75: 4173-4180. PMID: 17517877
62. Manzeniuk IN, Galina EA, Dorokhin VV, Kalachev I, Borzenkov VN, Svetoch EA. (1999) [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines]. Antibiot Khimioter 44: 21-26. PMID: 10494379
63. Nelson M, Prior JL, Lever MS, Jones HE, Atkins TP, Titball RW. (2004) Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. J Med Microbiol 53: 1177-1182. PMID: 15585494
64. Sarkar-Tyson M, Smither SJ, Harding SV, Atkins TP, Titball RW (2009) Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Vaccine 27: 4447-4451. doi: 10.1016/j.vaccine.2009.05.040 PMID: 19490962
65. Smith MD, Angus BJ, Wuthiekanun V, White NJ (1997) Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect Immun 65: 4319-4321. PMID: 9317042
66. Valade E, Thibault FM, Gauthier YP, Palencia M, Popoff MY, Vidal DR. (2004) The PmlI-PmlR quorumsensing system in Burkholderia pseudomallei plays a key role in virulence and modulates production of the MprA protease. J Bacteriol 186: 2288-2294. PMID: 15060030
67. Wikraiphat C, Charoensap J, Utaisincharoen P, Wongratanacheewin S, Taweechaisupapong S, Woods DE, et al. (2009) Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants. FEMS Immunol Med Microbiol 56: 253-259. doi: 10.1111/j.1574-695X.2009.00574.x PMID: 19549172
68. Warawa JM (2010) Evaluation of surrogate animal models of melioidosis. Front Microbiol 1: 141. doi: 10.3389/fmicb.2010.00141 PMID: 21772830
69. Atkins T, Prior R, Mack K, Russell P, Nelson M, Prior J, et al. (2002) Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol 51: 539-547. PMID: 12132769
70. Atkins T, Prior RG, Mack K, Russell P, Nelson M, Oyston PC, et al. (2002) A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun 70: 5290-5294. PMID: 12183585
71. Chin CY, Tan SC, Nathan S (2012) Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice. Front Cell Infect Microbiol 2: 85. doi: 10.3389/fcimb.2012.00085 PMID: 22919676
72. Hara Y, Mohamed R, Nathan S (2009) Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets. PLoS One 4: e6496. doi: 10.1371/journal.pone.0006496 PMID: 19654871
73. Jones SM, Ellis JF, Russell P, Griffin KF, Oyston PC (2002) Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. J Med Microbiol 51: 1055-1062. PMID: 12466403
74. Scott AE, Burtnick MN, Stokes MG, Whelan AO, Williamson ED, Atkins TP, et al. (2014) Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis. Infect Immun 82: 3206-3213. doi: 10.1128/IAI.01847-14 PMID: 24866807
75. Scott AE, Laws TR, D'Elia RV, Stokes MG, Nandi T, Williamson ED, et al. (2013) Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule. Clin Vaccine Immunol 20: 1041-1047. doi: 10.1128/CVI.00113-13 PMID: 23677322
76. Yingst SL, Facemire P, Chuvala L, Norwood D, Wolcott M, Alves DA. (2014) Pathological findings and diagnostic implications of a rhesus macaque (Macaca mulatta) model of aerosol-exposure melioidosis (Burkholderia pseudomallei). J Med Microbiol 63: 118-128. doi: 10.1099/jmm.0.059063-0 PMID: 24105842
77. Srilunchang T, Proungvitaya T, Wongratanacheewin S, Strugnell R, Homchampa P (2009) Construction and characterization of an unmarked aroC deletion mutant of Burkholderia pseudomallei strain A2. Southeast Asian J Trop Med Public Health 40: 123-130. PMID: 19323044
78. Wand ME, Muller CM, Titball RW, Michell SL (2011) Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol 11: 11. doi: 10.1186/1471-2180-11-11 PMID: 21241461
79. Chantratita N, Tandhavanant S, Wikraiphat C, Trunck LA, Rholl DA, Thanwisai A, et al. (2012) Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survival. J Proteomics 75: 1031-1042. doi: 10.1016/j.jprot.2011.10.015 PMID: 22062159
80. Chantratita N, Wuthiekanun V, Boonbumrung K, Tiyawisutsri R, Vesaratchavest M, Limmathurotsakul D, et al. (2007) Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei. J Bacteriol 189: 807-817. PMID: 17114252
81. Haussler S, Rohde M, von Neuhoff N, Nimtz M, Steinmetz I (2003) Structural and functional cellular changes induced by Burkholderia pseudomallei rhamnolipid. Infect Immun 71: 2970-2975. PMID: 12704181
82. Stevens MP, Friebel A, Taylor LA, Wood MW, Brown PJ, Hardt WD, et al. (2003) A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. J Bacteriol 185: 4992-4996. PMID: 12897019
83. Stevens MP, Wood MW, Taylor LA, Monaghan P, Hawes P, Jones PW, (2002) An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Mol Microbiol 46: 649-659. PMID: 12410823
84. Burtnick MN, DeShazer D, Nair V, Gherardini FC, Brett PJ (2010) Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect Immun 78: 88-99. doi: 10.1128/IAI.00985-09 PMID: 19884331
85. Pegoraro G, Eaton BP, Ulrich RL, Lane DJ, Ojeda JF, Bavari S, et al. (2014) A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages. BMC Microbiol 14: 98. doi: 10.1186/1471-2180-14-98 PMID: 24750902
86. Utaisincharoen P, Anuntagool N, Arjcharoen S, Limposuwan K, Chaisuriya P, Sirisinha S. (2004) Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages. Clin Exp Immunol 136: 277-283. PMID: 15086391
87. Utaisincharoen P, Tangthawornchaikul N, Kespichayawattana W, Anuntagool N, Chaisuriya P, Sirisinha S. (2000) Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin. Clin Exp Immunol 122: 324-329. PMID: 11122236
88. Chieng S, Carreto L, Nathan S (2012) Burkholderia pseudomallei transcriptional adaptation in macrophages. BMC Genomics 13: 328. doi: 10.1186/1471-2164-13-328 PMID: 22823543
89. Galyov EE, Brett PJ, DeShazer D (2010) Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol 64: 495-517. doi: 10.1146/annurev.micro.112408.134030 PMID: 20528691
90. Mulye M, Bechill MP, Grose W, Ferreira VP, Lafontaine ER, Wooten RM. (2014) Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages. PLoS Negl Trop Dis 8: e2988. doi: 10.1371/journal.pntd.0002988 PMID: 25144195
91. Valvano MA, Keith KE, Cardona ST (2005) Survival and persistence of opportunistic Burkholderia species in host cells. Curr Opin Microbiol 8: 99-105. PMID: 15694863
92. Welkos SL, Bozue JA, Cote CK (2011) The interactions between Bacillus anthracis and macrophages. In: Bergman N, editor. Bacillus anthracis and anthrax. Hoboken, NJ: Wiley-Blackwell. pp. 179-208.
93. Bozue J, Mou S,Moody KL, Cote CK, Trevino S, Fritz D,et al. (2011) The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis. Microb Pathog 50: 314-321. doi: 10.1016/j.micpath.2011.02.005 PMID: 21320584
94. Lauriano CM, Barker JR, Yoon SS, Nano FE, Arulanandam BP, Hassett DJ, et al. (2004) MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc Natl Acad Sci U S A 101: 4246-4249. PMID: 15010524
95. Pujol C, Grabenstein JP, Perry RD, Bliska JB (2005) Replication of Yersinia pestis in interferon gammaactivated macrophages requires ripA, a gene encoded in the pigmentation locus. Proc Natl Acad Sci U S A 102: 12909-12914. PMID: 16120681
96. Pujol C, Klein KA, Romanov GA, Palmer LE, Cirota C, Zhao Z, et al. (2009) Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification. Infect Immun 77: 2251-2261. doi: 10.1128/IAI.00068-09 PMID: 19289509
97. Breitbach K, Rottner K, Klocke S, Rohde M, Jenzora A, Wehland J, et al. (2003) Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol 5: 385-393. PMID: 12780776
98. Challacombe JF, Stubben CJ, Klimko CP, Welkos SL, Kern SJ, Bozue JA, et al. (2014) Interrogation of the Burkholderia pseudomallei Genome to Address Differential Virulence among Isolates. PLoS One 9: e115951. doi: 10.1371/journal.pone.0115951 PMID: 25536074